MatthewJoseph KDouglasMD

Emergency Medicine • Goodyear, AZ

Physician Executive, Emergency Medicine, and Clinical Research Physician

Join to view full profile

Dr. Douglas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Douglas' full profile

Already have an account?

Office
13677 W McDowell Rd
Goodyear, AZ 85395
Is this information wrong?

Summary

Physician Executive, Emergency Medicine Physician, and Clinical Research Principal Investigator with expertise in executive healthcare management. Skilled in leading clinical operations and providing strategic direction to improve healthcare delivery and patient care.

Highly accomplished healthcare professional with a foundation in emergency medicine, currently pursuing MBA. Brings a unique combination of medical knowledge, leadership, and business acumen. Successfully provides exceptional patient care, leads cross-functional teams, champions quality improvements, and consistently achieves organizational objectives. Employ data-driven approaches to influence business and healthcare decisions and strategies. With an innate drive for innovation and a deep understanding of the healthcare landscape, positioned to bridge the gap between clinical practice and business strategy, driving transformative solutions that amplify healthcare outcomes.

Education & Training

Arizona State University W. P. Carey School of BusinessExecutive MBA, Business, 2022 - 2024
University of Arizona College of Medicine-TucsonResidency, Emergency Medicine, 2014 - 2017
University of Arizona College of MedicineClass of 2014

Certifications & Licensure

AZ State Medical License 2016 - 2025
CA State Medical License 2023 - 2025
OR State Medical License 2020 - 2023
American Board of Emergency Medicine Emergency Medicine

Clinical Trials

New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED) Start of enrollment: 2022 Dec 06
Recruiting
Not Applicable
A Study of mRNA-1083 (SARS-Cov-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age Start of enrollment: 2023 Oct 19
Active, not recruiting
Phase 3
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension Start of enrollment: 2021 Jun 26
Completed
Phase 3
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension Start of enrollment: 2021 Jun 06
Completed
Phase 3
Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD) Start of enrollment: 2023 Mar 02
Completed
Phase 2
A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age Start of enrollment: 2023 Sep 25
Active, not recruiting
Phase 3
A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain Start of enrollment: 2023 Oct 05
Recruiting
Phase 2
A Study of LY3305677 in Participants With Obesity Or Overweight Start of enrollment: 2022 Nov 16
Completed
Phase 1
A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes Start of enrollment: 2023 Jul 20
Recruiting
Phase 2
A Study to Evaluate the Safety and Immunogenicity of IVX-A12 in Participants of 60 to 85 Years of Age Start of enrollment: 2023 May 15
Active, not recruiting
Phase 2
Study of Obeldesivir in Nonhospitalized Participants With COVID-19 Start of enrollment: 2023 Feb 08
Completed
Phase 3
Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study Start of enrollment: 2022 Dec 16
Active, not recruiting
Phase 2, Phase 3
A Study of mRNA-1283.222 Injection Compared With mRNA-1273.222 Injection in Participants ≥12 Years of Age to Prevent COVID-19 Start of enrollment: 2023 Mar 28
Active, not recruiting
Phase 3
Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants Start of enrollment: 2021 Nov 30
Completed
Phase 1
ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD) Start of enrollment: 2021 Sep 30
Completed
Phase 1
Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. Start of enrollment: 2021 Aug 31
Recruiting
Phase 3
Convalescent Plasma in Outpatients With COVID-19 Start of enrollment: 2020 Aug 11
Completed
Phase 3
Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression Start of enrollment: 2022 Feb 28
Recruiting
Phase 2
A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus Start of enrollment: 2023 Oct 24
Active, not recruiting
Phase 2
A Chronic Weight Management Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight Start of enrollment: 2023 Nov 17
Recruiting
Phase 2
A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight Start of enrollment: 2024 Feb 05
Recruiting
Phase 2
A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight Start of enrollment: 2023 Nov 17
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

25 citations
Drone Transport of Chemistry and Hematology Samples Over Long Distances.
Timothy K. Amukele, James S Hernandez, Christine L.H. Snozek, Ryan G. Wyatt, Matthew J. K. Douglas, Richard Amini, Jeff Street> ;American Journal of Clinical Pathology. 2017 Nov 2
17 citations
Management of Patients with Predicted Difficult Airways in an Academic Emergency Department
John C. Sakles, Matthew J. K. Douglas, Cameron Hypes, Asad E. Patanwala, Jarrod Mosier> ;The Journal of Emergency Medicine. 2017 Aug 1
27 citations
Can emergency physicians perform common carotid Doppler flow measurements to assess volume responsiveness
Lori A Stolz, Jarrod Mosier, Austin Gross, Matthew J. K. Douglas, Michael Blaivas, Srikar Adhikari> ;The Western Journal of Emergency Medicine. 2015 Jan 1
44 citations
Detection of in vivo enzyme activity with CatalyCEST MRI
Byunghee Yoo, Vipul R. Sheth, Christine M. Howison, Matthew J. K. Douglas, Carlos T. Pineda, Erin A. Maine, Amanda F. Baker, Mark D. Pagel> ;Magnetic Resonance in Medicine. 2014 Mar 1
Join now to see all

Journal Articles

Management and Outcomes of the Difficult Airway in the Emergency Department
Sakles JC, Douglas MJK, Hypes CD, Patanwala AE, Mosier JM, Society of Airway Management, 9/1/2016
Comparison of the C-MAC and GlideScope-Mac for Intubation in the Emergency Department
Dicken J, Conser E, Douglas M, Arcaris B, Patanwala AE, Sakles JC, Annals of Emergency Medicine, 2016
Ultrasound for critical care physicians: shortness of breath.
Douglas MJK, Verbunker D, Mosier J, Southwest J Pulm Crit Care, 9/10/2015
Can Emergency Physicians Obtain Measurements Of Common Carotid Doppler Flow To Assess Volume Responsiveness?
Stolz L, Mosier J, Gross A, Douglas M, Blaivas M, Adhikari S, Annals of Emergency Medicine, 10/1/2014
Join now to see all